Tronox Holdings (TROX) Q1 Losses And Ongoing Unprofitability Test Turnaround Narratives

Tronox Holdings Plc

Tronox Holdings Plc

TROX

0.00

Tronox Holdings (TROX) opened 2026 with Q1 revenue of US$760 million, a basic EPS loss of US$0.65 and a net income loss of US$103 million. On a trailing twelve month basis, revenue stood at US$2.9 billion with a basic EPS loss of US$2.91 and a net income loss of US$462 million. Over the past five reported quarters, revenue has moved from US$738 million in Q1 2025 to US$760 million in Q1 2026, while quarterly basic EPS losses have ranged between US$0.53 and US$1.11, keeping margins under pressure and putting the spotlight on how quickly management can repair profitability.

See our full analysis for Tronox Holdings.

With the latest results on the table, the next step is to line these hard numbers up against the dominant narratives around Tronox Holdings and see which views hold up and which need a rethink.

NYSE:TROX Revenue & Expenses Breakdown as at May 2026
NYSE:TROX Revenue & Expenses Breakdown as at May 2026

Losses remain heavy at US$462 million over 12 months

  • On a trailing basis, Tronox reported US$2.9 billion of revenue and a net loss of US$462 million, with basic EPS at a loss of US$2.91 over the last 12 months.
  • Consensus narrative expects margin improvement over time; however, the current trailing net loss of US$462 million and revenue growth of 5.2% a year versus the cited 11.4% US market rate show the business still working through weak profitability and only moderate top line expansion.
    • Analysts looking for future margin recovery have to square that view with multi year widening losses and margins that remain negative on the latest trailing figures.
    • With trailing EPS at a loss of US$2.91 and no profitability over the last 12 months, the story today is still about repair rather than expansion.

Share price at US$8.42 against DCF fair value of US$13.34

  • The stock trades at US$8.42 while the provided DCF fair value is US$13.34, and the shares sit on a P/S of 0.5x compared with a 1.2x US Chemicals industry average.
  • Bulls point to the valuation gap and cost savings plans; however, the current 36.9% modelled discount to fair value sits alongside trailing revenue growth of 5.2% a year and an unprofitable 12 month period, so investors need to weigh cheap P/S multiples against a business that is still loss making.
    • Bullish views that cost programs and new projects could lift margins have to contend with a trailing net loss of US$462 million and negative EPS across each of the last five reported quarters.
    • At the same time, a P/S of 0.5x and a share price below the DCF fair value leave room for those bullish on a longer term turnaround story to focus on the potential upside if fundamentals improve.
Over US$2.9 billion of trailing revenue with ongoing losses has many bulls arguing the valuation gap could matter if margins recover, which is exactly the kind of scenario they explore in the 🐂 Tronox Holdings Bull Case.

Dividend and debt coverage remain stress points

  • The company pays a dividend yield of about 2.38% while remaining unprofitable on a trailing basis and carrying debt that is not well covered by operating cash flow.
  • Bears highlight these balance sheet pressures, and the combination of weak dividend coverage, leverage that is not supported by operating cash flow, and recent share price volatility plus insider selling over the past three months backs a cautious stance around how much downside protection the current capital structure really offers.
    • With the last 12 months still showing a net loss of US$462 million and negative EPS, paying a dividend at 2.38% without earnings or free cash flow coverage aligns with the bearish concern around capital allocation risk.
    • Debt that is not well covered by operating cash flow, alongside short term share price swings and insider selling, fits the bearish focus on financial flexibility and potential pressure if trading conditions stay challenging.
If you want to see how these balance sheet concerns fit into the more cautious case, skeptics set out their full argument in the 🐻 Tronox Holdings Bear Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Tronox Holdings on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of risks and potential rewards feels finely balanced, take a closer look at the numbers now and decide where you stand with the 2 key rewards and 4 important warning signs.

See What Else Is Out There

Tronox Holdings is still working through sizeable losses, pressured margins, and balance sheet strain, which together raise questions about resilience if conditions stay tough.

If you are concerned about those pressures and want stocks where financial strength is front and center, check out the solid balance sheet and fundamentals stocks screener (44 results) to focus on companies with sturdier foundations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.